fruquintinib,bevacizumab
takeda,roche
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'fruquintinib', 'ts,perio,1', ' bev ', ' rev ', 'ts,perio,i']
 therapy options for later mcrc lines 
MD-PhD, MSc
Passionate Oncologist
Focus on Molecular Oncology 
Focus on Gastrointestinal Oncology